Page last updated: 2024-11-08

l 366948

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

L 366948: oxytocin antagonist; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44209670
MeSH IDM0183476

Synonyms (8)

Synonym
l 366948
L004680
127819-97-0
l 366,948
cyclo(3-(2-naphthalenyl)-d-alanyl-l-isoleucyl-d-2-piperidinecarbonyl-l-2-piperidinecarbonyl-d-histidyl-l-prolyl)
cyclo(pro-nal-ile-pip-pip-his)
cyclo(prolyl-naphthylalanyl-isoleucyl-pipecolyl-pipecolyl-histidyl)
AKOS040745974

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" shifted the dose-response for OT-induced uterine contraction to the right by approximately 5-fold but did not affect the dose-response to prostaglandin F2 alpha."( Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
Bock, MG; Clineschmidt, BV; Cook, MJ; Cukierski, MA; Haluska, GJ; Kaufman, MJ; Lis, EV; Novy, MJ; Pettibone, DJ; Reiss, DR, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's9 (90.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]